Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ ABIONYX Pharma Is Launching a Capital Increase With Cancellation of Preferential Subscription Rights in... (Business Wire) +++ ABIONYX Aktie -4,27%

NOVONESIS Aktie

 >NOVONESIS Aktienkurs 
52.54 EUR    +0.6%    (Tradegate)
Ask: 52.58 EUR / 100 Stück
Bid: 52.46 EUR / 100 Stück
Tagesumsatz: 758 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
NOVONESIS Aktie über LYNX handeln
>NOVONESIS Performance
1 Woche: -2,5%
1 Monat: -5,2%
3 Monate: -1,3%
6 Monate: -19,3%
1 Jahr: -6,1%
laufendes Jahr: -4,1%
>NOVONESIS Aktie
Name:  NOVONESIS A/S NAM. B DK 2
Land:  Dänemark
Sektor:  Chemie
ISIN/ Wkn:  DK0060336014 / A1JP9Y
Symbol/ Ticker:  NZM2 (Frankfurt)
Kürzel:  FRA:NZM2, ETR:NZM2, NZM2:GR
Index:  -
Webseite:  https://www.novonesis.com..
Profil:  Novonesis A/S is a leading specialty chemicals com..
>Volltext..
Marktkapitalisierung:  24438.33 Mio. EUR
Unternehmenswert:  27228.3 Mio. EUR
Umsatz:  -
EBITDA:  -
Nettogewinn:  -
Gewinn je Aktie:  -
Schulden:  3098.12 Mio. EUR
Liquide Mittel:  280.44 Mio. EUR
Operativer Cashflow:  -
Bargeldquote:  0.26
Umsatzwachstum:  -
Gewinnwachstum:  -
Dividende je Aktie:  0.86 EUR
Dividendenrendite:  1.58%
Dividendenschätzung:  1.64%
Div. Historie:  21.08.25 - 0.301095€
04.04.25 - 0.56204396€
>weitere anzeigen...
Insiderhandel:  -
Suchwörter:  NOVONESIS, NOVOZYMES
Letzte Datenerhebung:  17.12.25
>NOVONESIS Kennzahlen
Aktien/ Unternehmen:
Aktien: 411.94 Mio. St.
Frei handelbar: 83.49%
Leerverk. Aktien: -
Rückkaufquote: -
Mitarbeiter: 10582
Umsatz/Mitarb.: 0.32 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 22.32%
Bewertung:
KGV: -
KGV lG: 28.6
KUV: -
KBV: 2.3
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: -
Operative Marge: -
Managementeffizenz:
Gesamtkaprendite: -
Eigenkaprendite: -
>NOVONESIS Peer Group

Es sind 2 Aktien bekannt.
 
28.11.25 - 21:48
Novonesis: JPM setzt Aktie auf Focus List - großes Potenzial (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
28.11.25 - 09:27
Novonesis added to JPM Focus List as analysts lift PT to Dkr560 on growth outlook (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.25 - 21:06
Novozymes A/S reports Q3 results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.25 - 12:36
AI, Cost Cuts Drive Most US Layoffs In October Since 2003 | The Pulse 11/6 (Bloomberg)
 
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops. Today's guests: Estelle Brachlianoff, Veolia CEO; Jari Stehn, Goldman Sachs; Ester Baiget, Novonesis President & CEO (Source: Bloomberg)...
06.11.25 - 11:15
Novonesis delivered 8% organic sales growth in the first nine months of 2025 (GlobeNewswire EN)
 
Novonesis delivered 8% organic sales growth in the first nine months of 2025 and narrowed full-year outlook upwards. ...
04.11.25 - 15:15
Trading by management and close relations of management (GlobeNewswire EN)
 
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen matching shares program and the legacy Chr. Hansen 2023 restricted stock units (RSU) program. ...
23.10.25 - 13:06
Noma and Novonesis partner to scale deliciousness (GlobeNewswire EN)
 
Noma and Novonesis partner to scale deliciousnessNoma, hailed as one of the world's best restaurants, is joining forces with Novonesis, the global leader in biosolutions, to take deliciousness to the next level. Together, they're fusing culinary craft with biology to create flavors and products that are healthier, tastier, and better for the planet....
21.10.25 - 15:48
Novo Holdings to make changes to its Board of Directors (PR Newswire)
 
COPENHAGEN, Denmark, Oct. 21, 2025 /PRNewswire/ -- Novo Holdings plans to elect Lars Green, former CFO of Novozymes (now Novonesis), as Chair of its Board of Directors and Britt Meelby Jensen, CEO of Ambu, as Vice Chair. Lars Rebien Sørensen will step down as Chair. Lars Green has more......
06.10.25 - 16:03
Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters (GlobeNewswire EN)
 
Franklinton, NC, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Novonesis, a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its facilities in Salem, Virginia; West Allis and Madison, Wisconsin; and its North American headquarters in Franklinton, North Carolina, for the national flagship Manufacturing Day (MFG Day), a grassroots movement of the Manufacturing Institute (MI). The MI is the workforce development and education affiliate of the National Association of Manufacturers (NAM). The MI's mission is to build and strengthen the manufacturing workforce of the future....
09.09.25 - 13:00
Novonesis and Novo Nordisk collaborate on gut microbiome research initiative (PBR)
 
The gut microbiome is composed of microorganisms, including viruses, bacteria, and fungi, that naturally reside in the human gut. The companies will work together to investigate solutions aimed The post Novonesis and Novo Nordisk collaborate on gut microbiome research initiative appeared first on Pharmaceutical Business review....
08.09.25 - 08:45
Novonesis and Novo Nordisk will explore new solutions to improve metabolic health (GlobeNewswire EN)
 
Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people....
04.09.25 - 23:51
XETR: NEW INSTRUMENT AVAILABLE - 05.09.2025 - DK0060336014 (XETRA)
 
Das Instrument NZM2 DK0060336014 NOVONESIS A/S NAM. B DK 2 EQUITY hat seinen ersten Handelstag am 05.09.2025: CONTINUOUS TRADING WITH AUCTIONS, PAG SKA0, SettlCurr EUR, CCP Y The instrument NZM2 DK0060336014 NOVONESIS A/S NAM. B DK 2 EQUITY has its first trading date on 05.09.2025: CONTINUOUS TRADING WITH AUCTIONS, PAG SKA0, SettlCurr EUR, CCP Y...
24.08.25 - 21:27
XFRA: DIVIDEND/INTEREST INFORMATION - 25.08.2025 - DK0060336014 (XETRA)
 
Das Instrument NZM2 DK0060336014 NOVONESIS A/S NAM. B DK 2 EQUITY wird ex Dividende/Zinsen gehandelt am 25.08.2025 The instrument NZM2 DK0060336014 NOVONESIS A/S NAM. B DK 2 EQUITY has its ex-dividend/interest day on 25.08.2025...
21.08.25 - 12:18
Vance Says Russia Wants Territory That′s Under Ukraine′s Control | The Pulse 8/21/2025 (Bloomberg)
 
Federal Reserve Governor Lisa Cook signaled her intention to remain at the central bank, despite calls for her resignation by President Donald Trump over allegations of mortgage fraud. Cook said she will gather accurate information to answer any legitimate questions and provide the facts, and that she has no intention of being bullied to step down from her position. Senator Elizabeth Warren said the Trump administration "should not weaponize the federal government to illegally fire independent Fed Board members", according to her emailed statement. Meanwhile, Vice President JD Vance said negotiations over ending Russia's war in Ukraine are focused on security guarantees for Ukraine and territory Russia wants to control. Today's guests: Karen Ward, JPMorgan Asset Management EMEA Chief Market Strategist, Ester Baiget, Novonesis CEO (Source: Bloomberg)...
21.08.25 - 12:03
Novozymes A/S Non-GAAP EPS of €0.78, revenue of €2.09B (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.08.25 - 10:12
Novonesis shares tumble on earnings, margin miss despite sales guidance raise (Investing.com)
 
Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...
21.08.25 - 08:06
Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8% (GlobeNewswire EN)
 
COPENHAGEN, Denmark – August 21, 2025. Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%....
20.08.25 - 19:39
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement (GlobeNewswire EN)
 
COPENHAGEN, Denmark - August 20, 2025. Novonesis today announces its 'GROW' strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030, the company expects to deliver an organic sales CAGR of 6-9%, an adjusted EBITDA margin of ~39% and an adjusted ROIC excl. goodwill of ~16%....
20.08.25 - 17:48
2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement (GlobeNewswire EN)
 
Novonesis today announces its 'GROW' strategy and long-term targets for the strategy period until 2030 focusing on an acceleration of the core business and significant re-investments to secure long-term growth. By 2030, the company expects to deliver an organic sales CAGR of 6-9%, an adjusted EBITDA margin of ~39% and an adjusted ROIC excl. goodwill of ~16%....
30.06.25 - 19:06
Transactions under Novonesis′ share buyback program (GlobeNewswire EN)
 
Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated  1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Mensch ward zum Tun und nicht zum Vernünfteln erschaffen. Aber eben deswegen, weil er nicht dazu erschaffen ward, hängt er diesem mehr als jenem nach. - Gotthold Ephraim Lessing
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!